Over recent years, there has been a renewed interest in the development of L-nucleosides as safe and efficacious drugs for the treatment of viral infections. Biological activity of these compounds requires phosphorylation to their triphosphate form, involving nucleoside monophosphate kinases in the second step. In order to characterize the activation pathway of L-nucleosides of the pyrimidine series, we studied the enantio-selectivity of human uridylate-cytidylate and thymidylate kinases. The results showed that these enzymes are only weakly enantio-selective and are thus probably involved in the activation of L-nucleosides in vivo. An activation pathway for telbivudine (L-dT) was therefore proposed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/15257770701534014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Artificial Metalloenzymes Based on the Biotin-Streptavidin Technology: Enzymatic Cascades and Directed Evolution.
Acc Chem Res
March 2019
Department of Chemistry , University of Basel, BPR1096, Mattenstrasse 24a , CH-4058 Basel , Switzerland.
Article Synopsis
- Artificial metalloenzymes (ArMs) are created by anchoring metal-containing parts within protein or oligonucleotide scaffolds, effectively combining properties of both enzymes and homogeneous catalysts for enhanced reaction efficiency.
- The Ward group has utilized biotin-(strept)avidin technology to localize catalytic elements within stable protein frameworks, leading to successful genetic and chemical optimizations that improve selectivity, broaden substrate range, and boost activity.
- Current research aims to integrate ArMs into complex biological systems and cascades, mimicking natural metabolic regulation and demonstrating their compatibility with existing enzymes for potential in vivo applications.
Enantioselective metabolism of primaquine by human CYP2D6.
Malar J
December 2014
The National Center for Natural Products Research, University of Mississippi, University, MS 38677, USA.
Background: Primaquine, currently the only approved drug for the treatment and radical cure of Plasmodium vivax malaria, is still used as a racemic mixture. Clinical use of primaquine has been limited due to haemolytic toxicity in individuals with genetic deficiency in glucose-6-phosphate dehydrogenase. Earlier studies have linked its therapeutic effects to CYP2D6-generated metabolites.
View Article and Find Full Text PDFMetabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids.
J Lipid Res
August 2012
Department of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, TN 37232-0146, USA.
Human cytochrome P450 (P450) 2W1 is still considered an "orphan" because its physiological function is not characterized. To identify its substrate specificity, the purified recombinant enzyme was incubated with colorectal cancer extracts for untargeted substrate searches using an LC/MS-based metabolomic and isotopic labeling approach. In addition to previously reported fatty acids, oleyl (18:1) lysophosphatidylcholine (LPC, lysolecithin) was identified as a substrate for P450 2W1.
View Article and Find Full Text PDFStructure-activity relationships of hypervalent organochalcogenanes as inhibitors of cysteine cathepsins V and S.
Bioorg Med Chem
March 2011
Instituto de Química, Universidade de São Paulo, Av. Prof. Lineu Prestes 748, SP 05508-900, São Paulo, Brazil.
A new series of organotelluranes were synthesized and investigated, and the structure-activity relationships in cysteine proteases inhibition were determined. It was possible to identify the relevance of structural components linked to the reactivity of these compounds as inhibitors. For example, dibromo-organotelluranes showed to be more reactive than dichloro-organotelluranes towards cysteine cathepsins V and S.
View Article and Find Full Text PDFEnantio-selectivity of human nucleoside monophosphate kinases.
Nucleosides Nucleotides Nucleic Acids
March 2008
Laboratoire d'Enzymologie Moléculaire et Fonctionnelle, FRE2852-CNRS-Université Paris 6, 4 place Jussieu, F-75005 Paris, France.
Over recent years, there has been a renewed interest in the development of L-nucleosides as safe and efficacious drugs for the treatment of viral infections. Biological activity of these compounds requires phosphorylation to their triphosphate form, involving nucleoside monophosphate kinases in the second step. In order to characterize the activation pathway of L-nucleosides of the pyrimidine series, we studied the enantio-selectivity of human uridylate-cytidylate and thymidylate kinases.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!